Aspire Biopharma Holdings Statistics
Total Valuation
ASBP has a market cap or net worth of $7.77 million. The enterprise value is $3.41 million.
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASBP has 1.30 million shares outstanding. The number of shares has increased by 222.62% in one year.
| Current Share Class | 1.30M |
| Shares Outstanding | 1.30M |
| Shares Change (YoY) | +222.62% |
| Shares Change (QoQ) | +83.94% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 0.99% |
| Float | 1.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 224.90 |
| Forward PS | n/a |
| PB Ratio | 0.26 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 98.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.26 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.55 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -74.70% |
| Return on Invested Capital (ROIC) | -131.00% |
| Return on Capital Employed (ROCE) | -136.90% |
| Weighted Average Cost of Capital (WACC) | 88.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.91% in the last 52 weeks. The beta is 0.16, so ASBP's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -97.91% |
| 50-Day Moving Average | 6.09 |
| 200-Day Moving Average | 135.38 |
| Relative Strength Index (RSI) | 45.03 |
| Average Volume (20 Days) | 775,014 |
Short Selling Information
The latest short interest is 337,919, so 26.09% of the outstanding shares have been sold short.
| Short Interest | 337,919 |
| Short Previous Month | 123,876 |
| Short % of Shares Out | 26.09% |
| Short % of Float | 26.34% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, ASBP had revenue of $34,555 and -$11.76 million in losses. Loss per share was -$145.02.
| Revenue | 34,555 |
| Gross Profit | 5,634 |
| Operating Income | -5.43M |
| Pretax Income | -11.76M |
| Net Income | -11.76M |
| EBITDA | n/a |
| EBIT | -5.43M |
| Loss Per Share | -$145.02 |
Full Income StatementBalance Sheet
The company has $5.86 million in cash and $1.50 million in debt, giving a net cash position of $4.36 million or $3.36 per share.
| Cash & Cash Equivalents | 5.86M |
| Total Debt | 1.50M |
| Net Cash | 4.36M |
| Net Cash Per Share | $3.36 |
| Equity (Book Value) | 3.87M |
| Book Value Per Share | 23.10 |
| Working Capital | 3.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.21M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 2.68M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | 16.30% |
| Operating Margin | -15,707.06% |
| Pretax Margin | -34,039.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |